Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Kura Oncology
22 followers
REVOLUTION Medicines
19 followers
Kymera Therapeutics
7 followers
Dyne Therapeutics
6 followers
Celldex Therapeutics
5 followers
Arcturus Therapeutics
5 followers
Stemline Therapeutics
4 followers
Arcutis Biotherapeutics
3 followers
Active Motif
3 followers
Pivot Bio
2 followers
Avidity
4 followers
Scholar Rock
1 follower